Financials PharmX Technologies Limited Australian S.E.

Equities

PHX

AU000000COO1

Internet Services

Delayed Australian S.E. 08:15:24 2024-04-21 pm EDT 5-day change 1st Jan Change
0.03 AUD -3.23% Intraday chart for PharmX Technologies Limited -9.09% -26.83%

Valuation

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Capitalization 1 6.404 7.685 17.31 51.92 20.29 22.1
Enterprise Value (EV) 1 1.433 5.352 15.72 45.76 14.86 9.329
P/E ratio 25.5 x -1.83 x 84.5 x 43.5 x 85.2 x -20.8 x
Yield - - - - - -
Capitalization / Revenue 0.51 x 0.68 x 1.63 x 3.88 x 1.7 x 3.61 x
EV / Revenue 0.11 x 0.48 x 1.48 x 3.42 x 1.24 x 1.52 x
EV / EBITDA 1.53 x 6.25 x 16.8 x 27.2 x 16.1 x -42.6 x
EV / FCF -0.29 x -1.43 x -5.33 x 15 x -8.47 x -11 x
FCF Yield -346% -69.8% -18.8% 6.68% -11.8% -9.09%
Price to Book 0.45 x 0.77 x 1.31 x 2.26 x 0.87 x 1 x
Nbr of stocks (in thousands) 256,168 256,168 402,568 596,757 596,757 597,382
Reference price 2 0.0250 0.0300 0.0430 0.0870 0.0340 0.0370
Announcement Date 9/26/18 8/29/19 8/23/20 8/17/21 8/29/22 8/22/23
1AUD in Million2AUD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Net sales 1 12.57 11.23 10.64 13.38 11.95 6.127
EBITDA 1 0.939 0.856 0.937 1.682 0.921 -0.219
EBIT 1 0.65 0.561 0.685 1.236 0.369 -0.665
Operating Margin 5.17% 5% 6.44% 9.24% 3.09% -10.85%
Earnings before Tax (EBT) 1 0.65 -3.983 0.458 1.359 0.298 -0.719
Net income 1 0.251 -4.205 0.176 1.091 0.252 -1.051
Net margin 2% -37.44% 1.65% 8.15% 2.11% -17.15%
EPS 2 0.000979 -0.0164 0.000509 0.001999 0.000399 -0.001781
Free Cash Flow 1 -4.954 -3.736 -2.952 3.056 -1.754 -0.8484
FCF margin -39.42% -33.27% -27.74% 22.83% -14.67% -13.85%
FCF Conversion (EBITDA) - - - 181.66% - -
FCF Conversion (Net income) - - - 280.06% - -
Dividend per Share - - - - - -
Announcement Date 9/26/18 8/29/19 8/23/20 8/17/21 8/29/22 8/22/23
1AUD in Million2AUD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: June 2023 S2
Net sales 1 5.902
EBITDA 1 -0.517
EBIT 1 -0.29
Operating Margin -4.91%
Earnings before Tax (EBT) -
Net income -
Net margin -
EPS -
Dividend per Share -
Announcement Date 8/22/23
1AUD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 4.97 2.33 1.59 6.16 5.43 12.8
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -4.95 -3.74 -2.95 3.06 -1.75 -0.85
ROE (net income / shareholders' equity) 1.78% -34.7% 1.55% 6.04% 0.08% -3.89%
ROA (Net income/ Total Assets) 2.06% 2.02% 2.5% 3.06% 0.74% -1.24%
Assets 1 12.2 -208.5 7.033 35.68 33.94 85.08
Book Value Per Share 2 0.0600 0.0400 0.0300 0.0400 0.0400 0.0400
Cash Flow per Share 2 0.0200 0.0100 0.0100 0.0100 0.0100 0.0200
Capex 1 0.28 0.27 0.16 0.3 0.1 0.09
Capex / Sales 2.2% 2.4% 1.47% 2.24% 0.8% 1.39%
Announcement Date 9/26/18 8/29/19 8/23/20 8/17/21 8/29/22 8/22/23
1AUD in Million2AUD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. PHX Stock
  4. PHX Stock
  5. Financials PharmX Technologies Limited